These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 28342726)

  • 21. PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders.
    Shaw J; Scotchman E; Chandler N; Chitty LS
    Reproduction; 2020 Nov; 160(5):A1-A11. PubMed ID: 32130205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free DNA screening for fetal aneuploidy as a clinical service.
    Cuckle H; Benn P; Pergament E
    Clin Biochem; 2015 Oct; 48(15):932-41. PubMed ID: 25732593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-free fetal nucleic acid testing: a review of the technology and its applications.
    Sayres LC; Cho MK
    Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1p deletion syndrome: A prenatal diagnosis characterized by an abnormal 1st trimester combined screening test, yet a normal NIPT result.
    Yang CY; Kao CC; Chang SD; Huang SY
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):106-109. PubMed ID: 29458877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
    Guy C; Haji-Sheikhi F; Rowland CM; Anderson B; Owen R; Lacbawan FL; Alagia DP
    Mol Genet Genomic Med; 2019 Mar; 7(3):e545. PubMed ID: 30706702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update in non-invasive prenatal testing.
    D'ambrosio V; Squarcella A; Vena F; Di Mascio D; Corno S; Pajno C; Piccioni MG; Brunelli R; Pizzuti A; Benedetti Panici P; Giancotti A
    Minerva Ginecol; 2019 Feb; 71(1):44-53. PubMed ID: 30318870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma.
    Wong FC; Lo YM
    Annu Rev Med; 2016; 67():419-32. PubMed ID: 26473414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of chromosome abnormalities using current noninvasive prenatal testing: A multi-center comparative study.
    Du Y; Lin J; Lan L; Dong Y; Zhu J; Jiang W; Pan X; Lu Y; Li D; Wang L
    Biosci Trends; 2018 Jul; 12(3):317-324. PubMed ID: 29952350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Free Fetal DNA Testing for Prenatal Diagnosis.
    Drury S; Hill M; Chitty LS
    Adv Clin Chem; 2016; 76():1-35. PubMed ID: 27645814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
    Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
    Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for Implementing Cell-Free DNA Testing.
    Cuckle H
    Clin Lab Med; 2016 Jun; 36(2):213-26. PubMed ID: 27235907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for fetal chromosomal and subchromosomal disorders.
    Harris S; Reed D; Vora NL
    Semin Fetal Neonatal Med; 2018 Apr; 23(2):85-93. PubMed ID: 29128491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
    Sánchez-Usabiaga RA; Aguinaga-Ríos M; Batista-Espinoza A; Hurtado-Amador R; Romero-Tovar S
    Ginecol Obstet Mex; 2015 Apr; 83(4):220-31. PubMed ID: 26727755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic medicine in prenatal diagnosis.
    South ST; Chen Z; Brothman AR
    Clin Obstet Gynecol; 2008 Mar; 51(1):62-73. PubMed ID: 18303500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual Maternal and Fetal Findings With Cell-Free DNA Screening.
    Santoli CMA; Anastasio MK; Sparks TN; Dotters-Katz SK; Kuller JA
    Obstet Gynecol Surv; 2024 Sep; 79(9):539-546. PubMed ID: 39288158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non invasive prenatal testing (NIPT) for common aneuploidies and beyond.
    Alberry MS; Aziz E; Ahmed SR; Abdel-Fattah S
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():424-429. PubMed ID: 33550217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.
    Minear MA; Alessi S; Allyse M; Michie M; Chandrasekharan S
    Annu Rev Genomics Hum Genet; 2015; 16():369-98. PubMed ID: 26322648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of active Human CytomegaloVirus (hCMV) infection in pregnant women using data generated for noninvasive fetal aneuploidy testing.
    Faas BHW; Astuti G; Melchers WJG; Reuss A; Gilissen C; Macville MVE; Ghesquiere SAI; Houben LMH; Srebniak MI; Geeven G; Rahamat-Langendoen JC; Sistermans EA; Linthorst J
    EBioMedicine; 2024 Feb; 100():104983. PubMed ID: 38365322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.